OTCPicks.com

FEATURED COMPANY

MARINE EXPLORATION INCORPORATED (OTC: MEXP)
"Up 100.00% on Tuesday and 60.00% in morning trading today"

Detailed Quote: www.otcpicks.com/quotes/MEXP.php

Company Profile:
www.otcpicks.com/marine-exploration/marine-exploration-2.htm

Marine Exploration, Inc., a development stage company, engages in marine treasure hunting expeditions. It involves in the exploration and recovery of deep-ocean shipwrecks, including the marketing, sale, and distribution of recovered artifacts, replicas, merchandise, and books through various retail and wholesale sales channels. The company was incorporated in 1996 as Jenkon International, Inc. and changed its name to Multimedia K.I.D., Inc. in 1999. Later, it changed its name to SYCO, Inc. in 2006; and to Marine Exploration, Inc. in 2007. The company is based in Denver, Colorado.

MEXP News:

August 5 - Marine Exploration Inc. Acquires Ship

Marine Exploration, Inc. (OTC: MEXP) announced that it has executed a bill of sale acquiring the Ocean Lady, a 128 foot, 252 ton research vessel. The Ocean Lady, outfitted to the specifications of Burt Webber of Hispaniola Ventures, Marine's joint venture partner, is docked at Jones Boatyard Miami.

FEATURED COMPANY

PURIO INCORPORATED (OTCBB: PURO)
"Up 22.31% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PURO.php

Company Profile: http://www.otcpicks.com/purio/purio.htm

Purio Inc. owns proprietary water clarification technology suitable to a broad number of applications including the clarification of surface water, industrial process water and sewage. Purio intends to apply its technology initially to industrial and commercial applications to reclaim water and reduce the need for fresh water in such applications. Purio further intends to use its proprietary technology to produce potable water for commercial and residential use. Purio will commercialize its technology via a number of channels, namely licensing strategic partners to build and sell and/or operate units outside of North America, outright sale of their second generation (patent pending) units to end users and will build, own and operate on a fee for service basis their larger permanent installation units in North America. Purio is based in Blaine, Washington.

PURO News:

July 31 - Purio Inc. Completes Move of Compact Mobile Water Treatment System to Its First Demonstration Location

Purio Inc. (OTCBB: PURO) announced that it has completed the move of its compact mobile water treatment system to its first demonstration location.

"Our preliminary mechanical testing of the new unit was completed to our total satisfaction with all systems functioning superbly," says Earl Switenky, spokesmen for Purio.

"As planned, our first demonstration is designed to produce drinking water. The unit will be drawing water from a stagnant and polluted pond formerly used to water livestock," says Leonard Girard chief science officer for Purio. "This water certainly is unsuitable for human consumption as is, and this demonstration is designed to prove our unit's ability to produce safe drinking water from such sources economically."

Purio will be submitting water samples to recognized testing laboratories and reporting the results.

In the coming weeks the unit will be moved to a municipal location that will provide an ideal demonstration of the unit's capability to clarify and sanitize residential waste water for recycling purposes.

FEATURED COMPANY

COPPER KING MINING CORPORATION (OTC: CPRK)

Detailed Quote: www.otcpicks.com/quotes/CPRK.php

Company Profile:
www.otcpicks.com/copper-king-mining/copper-king-mining.htm

Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.

CPRK News:

August 5 - Copper King Mining Corporation Provides Project Updates

Copper King Mining Corporation (OTC: CPRK), an ore mining, processing and exploration company located in southern Utah, provided the following updates and a correction to a prior press release, concerning its mining and processing operations near Milford, Utah.

In response to several inquiries concerning a press release issued on March 24, 2008 by the company’s former investor relations firm without the company’s participation, Copper King’s management believes a correction to this press release is appropriate at this time.

Two power lines supply the power supply to the Copper King mill. One is approximately 3 ½ miles long and originates directly from the substation that will supply the mill concentrator with power. This supply line was rebuilt and upgraded by a local power utility, requiring new poles and other equipment. This utility upgrade now provides a connection point from which the company’s power line is now hooked south of the Ely Milford Highway. The company was assessed a substantial portion of the costs as its share of this improvement.

The company’s prior investor relations firm inadvertently confused pictures of this utility upgrade for the actual power line to the mill’s concentrator and issued a press release that included incorrect information about these two electrical connections.

In reality, nearly seven miles of new 46KV line has recently been built from the utility connection point to the company’s mill concentrator by the company’s contractor, Probst Electric of Heber, Utah, which construction should be completed this week. The company avers that the work performed by Probst Electric is unparalleled in light of cost, construction time and the quality work product. The company will issue more construction updates in the following weeks.

FEATURED COMPANY

U.S. MINE MAKERS INCORPORATED (OTC: USMM)

Detailed Quote: http://www.otcpicks.com/quotes/USMM.php

Company Profile:
http://www.otcpicks.com/us-mine-makers/us-mine-makers-2.htm

U.S. Mine Makers, Inc. is a US-based company engaged in "eco friendly" mining and processing of precious metals in Idaho, Nevada and Canada. The Company processes ore concentrate and hard rock ore to recover residual gold, platinum, rhodium and other precious metals from waste rocks of old abandoned mines. The Company`s goal is to process ore in a safe and economical manner, with little or no environmental impact.

USMM News:

August 4 - U.S. Mine Makers Goes 'Green' With Their Gold Recovery Process

U.S. Mine Makers, Inc. (OTC: USMM) prides itself as “eco-friendly,” and this company model is evident in the gold and platinum recovery process they have developed and are implementing in their new pilot plant. The company's new pilot plant and their future full-scale production plant are being designed to be much more environmentally friendly than gold processing plants that have traditionally used highly toxic forms of Cyanide to leach the gold from the ore. USMM has developed and tested a process that uses Sodium Bromide in place of Sodium Cyanide resulting in much more “eco-friendly” waste byproducts in their recovery process.

For years, mining and ore processing companies have been recovering gold and other precious metals using a Sodium Cyanide leaching process. The vast majority of gold mining companies have used this environmentally damaging process. Milling and heap leaching require cycling of millions of liters of alkaline water containing high concentrations of potentially toxic NaCN, free cyanide, and metal cyanide complexes that are frequently accessible and hazardous to wildlife. Some countries such as Argentina are starting to outlaw the use of Cyanide in gold and precious metal processing and the environmental impact is being investigated by other countries and environmental agencies as well.

The leach process that USMM is using utilizes Sodium Bromide (NaBR). Sodium Bromide and other waste byproducts in USMM's recovery process present a very low environmental hazard, and USMM's research has proven Sodium Bromide to be an effective and efficient catalyst in their metal leaching process.

U.S. Mine Makers CEO Ronald Bell stated, “Since our company's inception we have been committed to the use of environmentally friendly business practices and processes. For years we have been involved in the remediation and restoration of toxic mine sites, and now we are extending our 'eco-friendly' and 'Green' philosophy to our gold and platinum metals recovery process. We are committed to creating value for our shareholder in everything we do, but we also want to create that value in a sustainable and 'eco-friendly' way.”

FEATURED COMPANY

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

Detailed Quote: www.otcpicks.com/quotes/MGRN.php

Company Profile:
www.otcpicks.com/monogram-energy/monogram-energy.htm

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

July 29 - Monogram Energy, Inc. Addresses Shareholders

Monogram Energy, Inc. (OTC: MGRN) would like to update its shareholders on recent corporate events, in particular the activity relating to the Company’s common stock. Monogram Energy wants to assure its stockholders that the Company shares their concerns regarding the recent price drop of the stock, and is doing everything in its power to halt the slide. Monogram’s management is continuing to try and create shareholder value by acquiring wells, delivering oil produced by existing wells, and recognizing revenue. The Company continues its commitment to increase the production of existing and newly acquired wells.

Monogram's management realizes that not every stockholder is a long-term holder, but for those who are we ask that you request your shares in certificate form from your broker. Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc. stated, "We feel it's important that our shareholders know that we are reviewing and analyzing all available sources to try and pinpoint the causes of the price decline of our stock, and that we are taking whatever steps we can to find a solution."

Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.

STOCKS TO WATCH

VERENIUM CORPORATION (NASDAQ: VRNM)
"Up 46.04% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VRNM.php

Verenium Corporation, together with its subsidiaries, engages in the development and production of specialty enzyme products, and production and commercialization of biofuels. It operates in two segments, Biofuels and Specialty Enzymes. The Biofuels segment focuses on the production and commercialization of biofuels, primarily ethanol from cellulosic biomass. The Specialty Enzymes segment develops customized enzymes for use in alternative fuels, specialty industrial processes, and animal nutrition and health markets. Its products include Fuelzyme-LF, an alpha amylase enzyme, designed to improve the efficiency and economics of ethanol production from corn and other grain, or starch sources; Purifine enzyme for biodiesel applications; Amylase-T Transgenic Corn Amylase; Fuelzyme-CX enzymes for cellulosic ethanol; Purifine for edible oils; Luminase for pulp and paper processing; Phyzyme XP; Quantum phytase; Bayovac SRS that is designed to prevent disease in farmed Atlantic salmon; and Phytase-T, which supplements Quantum phytase. The company has strategic collaborations with Syngenta AG for the discovery and development of a range of novel enzymes; Bunge Oils, Inc. to discover and develop novel enzymes for the production of edible oil products; Cargill Health and Food Technologies to discover and develop novel enzymes for the production of a proprietary Cargill product; BASF AG to develop biocatalytic enzymes; DuPont Bio for the production of ethanol and other chemical products from corn biomass; and Bayer Animal Health to develop and market products to prevent infectious diseases in fish. It operates in North America, South America, Europe, Asia, and the Middle East. The company was founded in 1992 under the name Industrial Genome Sciences, Inc. and changed its name to Diversa Corporation in 1997. Further, it changed its name to Verenium Corporation in 2007. The company is headquartered in Cambridge, Massachusetts.

VRNM News:

August 6 - BP and Verenium Announce Significant Partnership to Accelerate the Commercialization of Cellulosic Ethanol

* Collaboration assembles core capabilities across biofuels value chain to accelerate commercial-scale cellulosic ethanol production using non-food feedstocks
* Initial phase includes $90 million in total funding by BP to Verenium over 18 months

BP and Verenium Corporation (Nasdaq: VRNM) announced the creation of a strategic partnership to accelerate the development and commercialization of cellulosic ethanol. The partnership combines a broad technology platform and operational capabilities in an effort to advance the development of a portfolio of low-cost, environmentally sound cellulosic ethanol production facilities in the United States, and potentially throughout the world. Under the initial phase of the strategic alliance, Verenium is to receive $90 million in total funding from BP over the next 18 months for rights to current and future technology held within the partnership.

"We are very excited and proud to be partnering with BP, a world leader in both the traditional and alternative energy industries that shares our commitment and vision to rapidly evolve next-generation ethanol into a commercial-scale solution for our energy needs," said Carlos A. Riva, President and Chief Executive Officer at Verenium. "In addition to BP's world-class capabilities in traditional energy production, logistics and distribution, their commitment to accelerate the development of the global biofuels market was a significant factor in our decision to partner with BP. In addition, both organizations are aligned on the significant market opportunity and operational imperatives for achieving rapid, commercial-scale success."

"BP is very pleased to be entering this important relationship with Verenium. We believe energy crops like sugar cane, miscanthus and energy cane are the best feedstocks to deliver economic, sustainable and scaleable biofuels to the world. This deal puts us at the front of the cellulosic biofuels game," said Sue Ellerbusch, president of BP Biofuels North America. "In partnering with Verenium, we now have the most advanced technology for transforming these energy grasses to biofuels, increasing our ability to invest earlier in the US to meet the requirements for cellulosic ethanol laid out in the recent energy bill. We also have the possibility of enhancing the productivity of our Brazilian assets. Verenium has already demonstrated the technology, making this real and an appropriate fit with our commitment to bring more sustainable biofuels to the market more quickly."

The initial phase of the strategic alliance utilizes Verenium's advanced technology for cellulosic ethanol production as the platform for a joint development effort between BP and Verenium. The companies have formed a Special Purpose Entity (SPE) that is equally owned by BP and Verenium, will license existing intellectual property from each company and own jointly-developed intellectual property in the field of cellulosic ethanol production. All intellectual property owned prior to the formation of the SPE will be retained by each respective company. Further, the SPE will serve as the licensing entity to enable all cellulosic ethanol production projects.

The financial terms of this initial phase of the strategic alliance include:

A) $45 million, payable in three installments over the next twelve months, for broad access to Verenium's cellulosic ethanol technology platform, production facilities, and employee scientific knowledge and expertise. At closing, Verenium will receive the first $24.5M of this amount.

B) $2.5 million per month to co-fund Verenium's various scientific and technical initiatives within the cellulosic ethanol field. The Companies' joint efforts in the field will be directed by a Joint Development Agreement, the initial term of which is 18 months.

Beyond the initial phase of this alliance, the companies expect to negotiate a second phase of the relationship focused on the development of a Joint Venture (JV) to accelerate the commercial deployment of the technologies from the SPE into commercial-scale cellulosic ethanol production facilities. While the primary and initial focus of the JV will be on facilities jointly owned by BP and Verenium in the United States, the SPE technologies may also be licensable to third-party commercial projects. It is the Companies' intention to negotiate and finalize this second phase of the strategic alliance, including incremental financial terms for co-funding the JV.

Lazard acted as financial advisor to Verenium in connection with the transaction.

ABOUT CELLULOSIC ETHANOL

Cellulosic ethanol is a renewable fuel source produced from biomass-derived products such as sugarcane waste (bagasse), switchgrass, rice straw and wood chips. Cellulose, a long-chain polysaccharide found in nearly all plant life, is the most abundant molecule on earth.

Cellulosic ethanol uses advanced biological science to reduce the cost of ethanol production and enable access to a wide variety of biomass. Unlike traditional ethanol manufactured from corn, cellulosic ethanol production utilizes non-food, plant biomass as its feedstock source. The biomass is first broken down into fermentable sugars using acid or enzymatic hydrolysis and industrial enzymes, after which the sugars are fermented into ethanol using various fermentation organisms. Ethanol produced from cellulosic biomass is believed to have many benefits over first-generation ethanol including, the use of non-food feedstock, substantially greater yield than grain ethanol per acre of feedstock, minimal exposure to volatile commodity price risks across the production process and a more favorable environmental impact. It also offers the potential to deliver significant greenhouse gas emission reductions of 80-90% compared to grain ethanol at GHG emission reductions of 0-70%.(1)

The Energy Bill

The production of cellulosic ethanol in the United States is supported by the Energy Independence and Security Act of 2007, which mandates 21 billion gallons of advanced biofuel production by 2022, of which 16 billion gallons must come from cellulosic ethanol.

ABOUT BP

BP is of one of the world's largest energy companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items. It is the largest oil and gas producer in the U.S. and one of the largest refiners. BP also has a global network of around 25,000 service stations.

BP is a leading player in the global biofuels market. In the US, BP blended and distributed 763 million US gallons of ethanol and about 1 million US gallons of biodiesel during 2007. In Europe, BP sold 344 million liters of ethanol and 847 million liters of biodiesel during 2007. BP's sales of biofuels in 2007 accounted for about 10% of the global biofuels market.

(1) GHG emissions reductions taken from Concawe Well-to-Wheels Report March 2007.

AMERIRESOURCE TECHNOLOGIES INCORPORATED (OTCBB: ARIO)
"Up 10.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ARIO.php

AmeriResource Technologies, Inc., through its subsidiaries, involves in software development for the fast-food and full service restaurant industry. It provides interactive self-service ordering software, and custom interfaces and systems for various kiosk applications in industries, including restaurants, payment systems, theaters, and sports and entertainment ticketing and informational systems, as well as offers free-standing floor, wall mounted, and counter-top hardware-kiosks. The company also provides software design and product development for businesses that are in the business of selling on eBay; and provides eBay liquidation services for excess inventory, overstocks, and merchandise that has been returned to the retailer. AmeriResource Technologies, Inc., formerly known as KLH Engineering Group, Inc., was incorporated in 1989 and is based in Las Vegas, Nevada.

ARIO News:

August 6 - AmeriResource Subsidiary RoboServer, Creates New Revenue Center, 'RoboServer Easy Pay'

AmeriResource Technologies, Inc. (OTCBB: ARIO) announced that its subsidiary, RoboServer Systems Corp. (OTC: RBSY), has established a new product and revenue center to serve city/government agencies and private corporations.

Delmar Janovec, CEO of AmeriResource comments, "RoboServer has created a new product line and revenue center, RoboServer Easy Pay. This newly created division of RoboServer offers a portfolio of customized integrated software applications. Examples include the processing of payments for utilities (water, electricity, and natural gas bills), franchise or property taxes, parking or speeding tickets, and many other opportunities for self-service payment processing. RoboServer Easy Pay is fully compatible with RoboServer stand-alone touch-screen kiosk models or RoboServer's innovative Assisted-Server Dual Screen counter-top model. The software application is very intuitive and fluid to provide the customer with a complete and satisfactory transaction while reducing costs and increasing productivity for the owner, whether private or governmental."

ABOUT ROBOSERVER SYSTEMS:

RoboServer Systems Corp. (OTC: RBSY), is a software developer and touch-screen system integrator for kiosks and other networking units that support point of sale (P.O.S.), self-service ordering and payment processing functions. In addition to kiosk hardware, operating system software, and client-defined customized touch-screen software applications, RoboServer can provide installation, training, software updates, and ongoing maintenance and support. RoboServer is the one-stop provider of self-service solutions for multiple industries.

TECHALT INCORPORATED (OTC: TCLT)
"Up 100.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/TCLT.php

Techalt is a public holding company dedicated to pursuing acquisition, licensing and financing opportunities with start-up and mid-stage companies. Techalt focuses on companies with innovative or alternative technologies, particularly in the software, communications, environmental and health and wellness sectors.

TCLT News:

August 6 - Techalt, Inc. Announces Stan's Rodeo Ointment to be Dispensed at the 2008 Beijing Olympics

Techalt, Inc. (OTC: TCLT) ("Techalt" or "Company") announced Stan’s Rodeo Ointment (“SRO”) will be dispensed at the 2008 Beijing Olympic Games. SportPharm (the compounder of SRO, FDA licensed distributor and Subsidiary Compounding arm of HNP Pharmaceuticals) will be participating in its second Olympic Games as a member of the U.S. Olympic Medical Team. SportPharm will feature SRO at the Olympic Games and packages all of the medications it dispenses for use by the U.S. Olympic Team (athletes and staff).

Multiple NFL, NBA, MLB, NCAA, MLS and NHL teams utilize SportPharm’s dispensing databases to provide their organization with a majority of their pharmaceutical needs. As the Chief Pharmacist of SportPharm, Mike Pavlovich will be responsible for the management of all the dispensing databases and will serve as the only Pharmacist of the 45 member medical team. Additionally, he will provide medications and drug information services to athletes and staff alike, where he will be using SRO as an Olympic-Approved ointment to heal mild to severe dermal wounds.

“We feel the Beijing Olympics are an ideal platform to showcase the benefits athletes can realize when using SRO. We expect the visibility derived from dispensing SRO at the Beijing Olympics will help our sales and distribution efforts in the United States,” stated Techalt’s CEO David Moore.

Techalt is currently in the process of securing financing for (i) expanding SRO’s distribution channels and marketing efforts and (ii) completing the process for obtaining an over the counter designation from the United States Food and Drug Administration.

ABOUT HNP PHARMACEUTICALS (“HNP”)

HNP Pharmaceuticals is a nationally recognized pharmaceutical compounding laboratory, specializing in unique and patent-pending compounded formulations for orthopedic injuries. HNP is the primary compounding pharmacy for more than 70% of all professional athletes in the United States, the Olympics, and an ever-growing number of collegiate sports programs.

ABOUT STAN’S RODEO OINTMENT (“SRO”)

SRO is a sports cream designed to accelerate the healing time for abrasions, lacerations, blisters and other open wounds to the skin, while diminishing the pain that often results from such injuries. Developed by Stanley Johnston, former head athletic trainer for the Los Angeles Dodgers, SRO is currently available by prescription and used by prominent Olympic and professional athletes. Techalt also acquired the rights to develop Stan’s Blister Rub (“SBR”), a combination of materials that strengthen the skin after it has healed to reduce the likelihood of the reoccurrence of blisters. Patent protection has been filed covering the formulations and processing of SRO with the US Patent and Trademark Office. The Company anticipates that a patent will be issued sometime in 2008.

CAPITAL OIL & GAS CORPORATION (OTC: PODM)
"Up 28.57% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PODM.php

Capital Oil & Gas operates retail filling stations/convenience stores throughout the State of Florida; the company is aggressively seeking additional acquisitions that can meet or exceed its current growth plan. Visit www.capitaloilgroup.net for more information.

PODM News:

August 5 - Capital Oil & Gas, Inc. To Add Express Pizza & Sub Sandwiches to its Locations

Capital Oil & Gas, Inc. To Add Express Pizza & Sub Sandwiches to its Locations

Capital Oil & Gas, Inc. (OTC: PODM) announced that it will add franchised or corporate express pizza & sub sandwich operations to all of its locations current and future.

The company in following the more established oil & gas retailers that have McDonalds and other well known fast food operations at their locations, believes that this is the right move at the right time to maximize revenues.

Capital Oil & Gas estimates that revenue to the company will increase by $950,000 to $1,100,000 per year, per location with revenue generated by the fast food operations and the other cross marketing revenues.

Ariel Rodriguez President said, "Capital Oil & Gas said at first I was reluctant to add these products, and then when my staff provided me with the numbers I told them to run with it. I am an oil & gas man but if other retail operations add to the bottom line we go for it."

ABOUT CAPITAL OIL & GAS, INC.

Capital Oil & Gas operates retail filling stations/convenience stores throughout the State of Florida; the company is aggressively seeking additional acquisitions that can meet or exceed its current growth plan.

ULYSSES DIVERSIFIED (OTC: UDHC)
"Up 10.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/UDHC.php

Ulysses Diversified Holdings Corporation operates in the retail optical industry in the United States. It owns, operates, and franchises optical stores that offer eyewear, including contact lenses and non designer eyeglasses and sunglasses. The company also offers designer eyewear. Ulysses Diversified Holdings Corporation was formerly known as Ulysses Holding Corp. and changed its name to Ulysses Diversified Holdings Corporation in May 2008. The company was incorporated in 1994 and is based in Jacksonville, New York.

UDHC News:

August 6 - Ulysses Diversified Holdings Corp. in Negotiations With a Major National Day Care Chain for Its SecureNetView Unit Products and Services

Ulysses Diversified Holdings Corporation (OTC: UDHC) announced it has entered into formal negotiations to supply a major national day care operator with one thousand (1,000) plus locations.

The contract will consist of providing each of all one thousand plus locations with SecureNetView's patented surveillance technology, this technology enables parents to monitor their children at the day care centers from any cell phone, computer or any other hand-held device.

The company estimates monthly revenue from this one client account will range between $680,000 and $750,000 per month for an annual revenue flow of $8,160,000 to $9,000,000.

"We are very pleased to have this opportunity and believe that we are in the final stretch of obtaining this very lucrative contract, I am confident that our team will complete this deal by week's end," said Clayton Young, President.

Mr. Young also added, "Due to the sensitivity of the finalization of the contract by both parties, the client will be announced upon the completion of all executed contracts."

MEDQUIST INCORPORATED (NASDAQ: MEDQ)
"Up 13.27% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MEDQ.php

MedQuist, Inc. provides medical transcription technology and services in the United States. It also offers digital dictation, speech recognition, and electronic signature technologies. The company offers DocQment Enterprise Platform, a Web-based dictation and transcription management system, which integrates dictation capture, workflow management, speech recognition, medical transcription, and document distribution. Its maintenance services include onsite maintenance and remote "break-fix" services, as well as application, hardware, and software technical support for its products. In addition, the company offers SpeechQ for Radiology, a front-end speech recognition software application that allows radiologists to dictate, edit, and sign their reports in a single session or send them to an editor following dictation. Further, it offers DocQment Ovation, a Web-based enterprise digital voice capture and transport solution. The company serves health systems, hospitals, and large group medical practices. It also has a collaboration agreement with Philips Medical Systems for product development. The company was founded in 1984 and is headquartered in Mount Laurel, New Jersey. MedQuist, Inc. is a subsidiary of Koninklijke Philips Electronics N.V.

MEDQ News:

August 4 - MedQuist Announces Payment of $2.75 per share Dividend on Common Stock

MedQuist Inc. (Nasdaq: MEDQ) announced the payment of a dividend of $2.75 per share of MedQuist common stock to shareholders of record as of the close of business on July 25, 2008.

As previously announced, certain MedQuist shareholders filed a derivative lawsuit in New Jersey state court seeking to enjoin the payment of the dividend and the closing of the sale by Koninklijke Philips Electronics, N.V. of its approximately 69.5% ownership interest in MedQuist to CBay Systems Holdings, Limited, among other things. On August 1, 2008, the court denied the motion for preliminary injunctive relief in its entirety.

DYNAVAX TECHNOLOGIES CORPORATION (NASDAQ: DVAX)
"Up 11.18% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/DVAX.php

Dynavax Technologies Corporation, a biopharmaceutical company, discovers, develops, and commercializes Toll-like Receptor 9 (TLR9) agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases using proprietary approaches that alter immune system responses in specific ways. The company's TLR9 agonists are based on immunostimulatory sequences (ISS), which are short DNA sequences that enable the immune system to fight disease and control chronic inflammation. Its product candidates include HEPLISAV, a hepatitis B vaccine in Phase III clinical trial partnered with Merck & Co. Inc.; TOLAMBA, a ragweed allergy therapy in Phase II clinical trial; a therapy for metastatic colorectal cancer that is in Phase I clinical trial; and a therapy for hepatitis B in Phase I clinical trial. The company's preclinical asthma and chronic obstructive pulmonary disease (COPD) program is partnered with AstraZeneca AB. Dynavax Technologies Corporation was founded in 1996 under the name Double Helix Corporation and subsequently changed its name to Dynavax Technologies Corporation. The company is based in Berkeley, California.

DVAX News:

August 5 - Dynavax Announces Second Quarter 2008 Financial Results

Revenues Increase for Quarter, Per Share Net Loss Narrows

Dynavax Technologies Corporation (Nasdaq: DVAX) reported financial results for the second quarter and six months ended June 30, 2008.

As of June 30, 2008, Dynavax reported cash, cash equivalents, marketable securities and investments held by Symphony Dynamo, Inc. (SDI) totaling $63.1 million. This compares to $88.2 million at December 31, 2007.

For the second quarter 2008, total revenues were $10.0 million, compared to $1.8 million reported for the second quarter in 2007. Revenues for the six months ended 2008 were $16.3 million, compared to $3.8 million for the same period in 2007. The increase in revenues for the second quarter and year-to-date reflects research and development funding under our collaboration with Merck & Co. Inc. (Merck) for HEPLISAVTM, our hepatitis B vaccine product candidate. The reported revenues do not include collaboration funding from Symphony Dynamo Inc. (SDI) for cancer and HCV clinical activities. On a pro forma basis, including the collaboration funding from SDI, revenues were $11.4 million and $19.3 million for the three and six months ended June 30, 2008, respectively, compared to $4.9 million and $10.4 million for the same periods in 2007.

For the second quarter 2008, total operating expenses were $16.6 million, compared to $23.6 million for the second quarter in 2007. Operating expenses for the six months ended 2008 were $36.5 million, compared to $41.7 million for the same period in 2007. The decline in operating expenses for the second quarter and year-to-date resulted primarily from a reduction in clinical development costs. The operating expenses in 2007 also included a one-time license payment for the commercialization of HEPLISAV. Excluding the one-time and other non-cash charges for stock-based compensation and amortization of intangible assets, pro forma operating expenses were $15.6 million and $34.6 million for the three and six months ended June 30, 2008, respectively, compared to $17.7 million and $34.7 million for the same periods in 2007.

The tables included as part of this press release provide a reconciliation of GAAP revenues and operating expenses to pro forma revenues and operating expenses.

The net loss of $6.1 million, or $0.15 per share, reported for the second quarter 2008 improved from the net loss of $17.7 million, or $0.45 per share, for the same period in 2007. The net loss of $18.5 million, or $0.47 per share, reported for the six months ended 2008 was also significantly less than the net loss of $30.8 million, or $0.78 per share, for the same period in 2007. For the second quarter and year-to-date, the improvement in net loss reflected the increase in revenues, in particular, revenue associated with the Merck collaboration.